Skip to main content
Fig. 3 | BMC Pediatrics

Fig. 3

From: Changes in type 2 innate lymphoid cells and serum cytokines in sublingual immunotherapy in pediatric patients with allergic rhinitis

Fig. 3

After stimulation with HDM (20 μg/mL) and stimulating factors, no significant change of ILC2 frequency in PBMCs from SLIT group. Two-year SLIT decreased the ILC2 milieu activation ability in AR donor. #P > 0.05. HDM, house dust mite; ILC2, type 2 innate lymphoid cells; PBMCs, peripheral blood mononuclear cells; SLIT, sublingual immunotherapy; ILC2, type 2 innate lymphoid cells; AR, allergic rhinitis

Back to article page

BMC Pediatrics

ISSN: 1471-2431

Contact us